Effect of early statin and selective cyclooxygenase-2 inhibitor therapy on C-reactive protein level after percutaneous coronary angioplasty in unstable angina
Dariusz Dudek*, MD, PhD; Grzegorz Heba MD, PhD; Jacek Legutko MD, PhD; Michal Chyrchel MD; Tomasz Rakowski MD; Grzegorz L. Kaluza, MD PhD; Jacek S. Dubiel MD, PhD
Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland
Aims: We evaluated the effect of cyclooxygenase-2 inhibitor rofecoxib added to atorvastatin, initiated immediately after percutaneous coronary angioplasty (PCI), on C-reactive protein (CRP) and interleukin-6 (IL-